Puma Biotech to pay PPD founder $22M in defamation suit from proxy fight | Fierce Pharma
Puma Biotechnology, Inc. | LinkedIn
From summer lull to biotech's record-breaking month | Evaluate
Puma Genomes Reflect Inbreeding, Highlight Rescue Options
Puma Biotechnology - Crunchbase Company Profile & Funding
PUMA_BIOTECHNOLOGY
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News | Stock Analysis
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News | Stock Analysis
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology shares rocket after biopharma zips past Street's 4Q estimate
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News | Stock Analysis
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotech's Nerlynx Included In NCCN Guidelines For Breast Cancer - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
Why Puma Biotechnology Is Soaring Today | Nasdaq
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib | Nasdaq
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. IPO Investment Prospectus S-1
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
Reverse Mergers Losing Out to Lower-Cost Offerings - TheStreet
DFAN14A
